|
Match
|
Document |
Document Title |
|
|
US20090298943 |
Use of creatine analogues and creatine kinase modulators for the prevention and treatment of obesity and its related disorders
The present invention relates to the use of creatine compounds for treating or preventing a metabolic disorder related to body weight control such as obesity, and it's associated diseases in a...
|
|
|
US20090253797 |
CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT
Creatine oral supplementation using creatine hydrochloride salt, that may be added to a liquid or other beverage, or may be also used as an additive to solid oral dosages, or as a supplement, and...
|
|
|
US20090253765 |
Angiogenesis Inhibitor Containing Amine Derivative as Active Ingredient
An object of the present invention is to provide an angiogenesis inhibitor. The angiogenesis inhibitor according to the present invention contains a compound represented by the following general...
|
|
|
US20090221706 |
Methods of treating cognitive dysfunction by modulating brain energy metabolism
Methods for treating cognitive dysfunction by modulating brain energy metabolism are discussed.
|
|
|
US20090221536 |
TRANSDERMAL DELIVERY OF BENEFICIAL SUBSTANCES EFFECTED BY A HOSTILE BIOPHYSICAL ENVIRONMENT
The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical...
|
|
|
US20090203789 |
Fast Dissolution Amino Acid Composition
The present invention relates to oral dosage formulations for the rapid release of amino acids. A rapid release is achieved through the process of milling whereby the milled amino acids are more...
|
|
|
US20090202456 |
NOVEL SALTS AND THEIR USES
The invention relates to novel arginine salts, compositions comprising them, and their uses.
|
|
|
US20090186034 |
Gene expression markers for inflammatory bowel disease
The present invention relates to methods of gene expression profiling for inflammatory bowel disease pathogenesis, in which the differential expression in a test sample from a mammalian subject of...
|
|
|
US20090176743 |
Methods for treating or preventing reactivation of a latent herpesvirus infection
The invention is directed to methods and compositions for treating or preventing reactivation of a latent herpesvirus infection and the associated complications and outcomes. The methods involve...
|
|
|
US20090175925 |
PASSIVE TIME RELEASED SOLUTE TREATMENT
Devices and methods for delivery of a solute to increase blood sugar levels between certain hours in a form that allows for gradual delivery. One variation includes devices and methods for the...
|
|
|
US20090163592 |
Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
The present invention provides diacylhydrazine ligands and chiral diacylhydrazine ligands for use with ecdysone receptor-based inducible gene expression systems. Thus, the present invention is...
|
|
|
US20090156649 |
Cellular phosphorylation potential enhancing compositions preparation and use thereof
A pharmaceutical composition comprising as an active phosphorylation potential enhancing substance a pharmaceutically-acceptable salt of an alpha-keto carboxylic acid thereof alone or in...
|
|
|
US20090105336 |
Beneficial Effects of Increasing Local Blood Flow
The present invention provides a treatment for enhancing the ability of the body to heal wounds. A topical cream is described which improves blood flow by the transdermal delivery of the nitric...
|
|
|
US20090105196 |
USE OF CREATINE COMPOUNDS TO TREAT DERMATITIS
Creatine compounds for the treatment of dermatitis are described.
|
|
|
US20090069331 |
GUANIDINE DERIVATIVES AS INHIBITORS OF DDAH
Compounds of formula (I) have been found to be useful as inhibitors of DDAH. The present invention thus provides the use of a compound of formula (I), or a pharmaceutically acceptable salt thereof,...
|
|
|
US20090060922 |
Acetamide Stereoisomer
The compound of formula (I)
is a water-stable, long acting β 2 -selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible...
|
|
|
US20090023705 |
DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF MOOD DISORDERS, SLEEP DISORDERS OR ATTENTION DEFICIT DISORDERS
The present invention provides pharmaceutical compositions comprising droxidopa alone, or in combination with one or more further active ingredients, for the treatment of conditions, such as mood...
|
|
|
US20090005450 |
Use of creatine compounds for the treatment of eye disorders
The present invention provides methods of treating an eye disorder (i.e., glaucoma, macular degeneration, diabetic retinopathy, macular edema, ocular rosacea, amblyopia, cataracts, dry eye, iritis,...
|
|
|
US20080318987 |
METHODS FOR MODULATING BONE FORMATION AND MINERALIZATION
Methods and compositions for modulating bone formation and mineralization are described.
|
|
|
US20080317856 |
Compositions Containing A Capillary -Active System With Application -Relevant Differentiability, And The Use Thereof
This invention relates to compositions with a capillary-active system with application-relevant differentiability and synergistic potential for use in mammals, especially humans. The invention...
|
|
|
US20080306159 |
ENTERIC COATED, SOLUBLE CREATINE AND POLYETHYLENE GLYCOL COMPOSITION FOR ENHANCED SKELETAL UPTAKE OF ORAL CREATINE
An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene...
|
|
|
US20080300309 |
Creatine Hydroxycitric Acids Salts and Methods for their Production and use in Individuals
Methods of production for Tricreatine Hydroxycitrate are disclosed. Tricreatine hydroxycitrate can be used as supplemental dietary ingredient for the purposes of reducing adiposity, suppression of...
|
|
|
US20080280815 |
Lowering Serum Lipids
The present invention relates to a method for lowering serum lipids, eg. triglycerides and/or cholesterol in a subject comprising administering a GLP-1 agonist to said subject.
|
|
|
US20080275015 |
Formulation and Method for Treating Interstitial Cystitis and Related Bladder Conditions
The invention of this application relates to a formulation and method of using the formulation for the treatment of interstitial cystitis and other similar conditions of the bladder. The...
|
|
|
US20080274149 |
Encapsulation and Controlled Release of Biologically Active Ingredients with Enzymatically Degradable Microparticulate, Hyperbranched Polymers
The invention provides encapsulated, microparticulate active ingredient formulations for the controlled release of active ingredients on skin and skin appendages consisting of encapsulation...
|
|
|
US20080260861 |
Modulating Lymphatic Function
Methods and compositions for modulating lymphatic function, e.g., by altering NO levels, are disclosed.
|
|
|
US20080234380 |
Compositions and method for treatment of chronic inflammatory diseases
This invention defines novel compositions that can be used for clinical treatment of a class of chronic inflammatory diseases. Increased generation of carbonyl substances, namely aldehydes and...
|
|
|
US20080233186 |
DIETARY COMPOSITIONS AND METHODS OF ENHANCING LEAN BODY MASS AND EXERCISE PERFORMANCE
Various compounds can be administered orally to humans or animals for the purpose of enhancing nitric oxide production. Enhancing nitric oxide production is beneficial for those looking to increase...
|
|
|
US20080226616 |
Emulsifier Combination for Cosmetics
The present invention relates to a cosmetic preparation containing an emulsifier combination of polyacrylic acid salts, acrylate/C10-30 alkyl acrylate crosspolymer and carrageenan and the use of...
|
|
|
US20080206290 |
COSMETIC COMBINATION PRODUCT FOR IMPROVING APPEARANCE
A cosmetic combination product, wherein the product comprises at least two components selected from (a) one or more dietary supplements, (b) one or more cosmetic preparations for topical...
|
|
|
US20080206170 |
Creatine compositions for skin treatment
The present invention relates to the use of creatine compounds, such as, for example, creatine monohydrate, creatine pyruvate and creatine ascorbate, for the treatment of skin.
|
|
|
US20080182903 |
Formulation of a composition for treating various conditions by using lotion/cream including L-Arginine
Disclosed is a composition and method, for various conditions, including body weight control, sexual dysfunction, stomach blotting, heartburn, body pain, and controlling cholesterol, arginine is...
|
|
|
US20080182811 |
METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR
Amino acids other than glutamic acid are used as a metabotropic glutamate receptor activator. More preferably, aspartic acid, valine and cysteine are used as a group I metabotropic glutamate...
|
|
|
US20080160108 |
Method of treating muscular dystrophies with an inhibitor of histone deacetylase
The present invention relates to the use of an inhibitor of histone deacetylase for preparing a drug for the treatment or prevention of a disease resulting from the deficiency of an adult gene in...
|
|
|
US20080145424 |
Sustained release L-arginine formulations and methods of manufacture and use
The present invention provides methods and formulations for the treatment and prevention of cerebrovascular and cardiovascular diseases and disorders. The present invention is based, at least in...
|
|
|
US20080125424 |
Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
The present invention relates generally to compounds represented in Formula I, pharmaceutical compositions comprising them and methods of treating of diseases or disorders related to the function...
|
|
|
US20080119450 |
Use of creatine or creatine analogs for the treatment of diseases of the nervous system
The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system....
|
|
|
US20080118556 |
Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone
The invention relates to a multiparticulate modified release composition that, upon administration to a patient, delivers a combination of carbidopa, levodopa and entacapone in a bimodal,...
|
|
|
US20080108684 |
THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALFA PRODUCTION INHIBITOR
Disclosed is an agent for use in the treatment or prevention of inflammatory bowel disease. Also disclosed is an agent for inhibiting the production of TNF-α. A therapeutic or prophylactic agent...
|
|
|
US20080102137 |
Composition and method for etiological treatment and prevention of diseases and/or complications associated with chronic glucose metabolism destabilization
A natural composition formulated to modulate multiple pathophysiological processes in order to facilitate homeostatic glucose metabolism in a patient, and more particularly to increase insulin...
|
|
|
US20080064754 |
Amino ion releasing hydrogen bonded molecule
A free amino ion releasing molecule useful for a wide variety of medical and cosmetic applications. The chemical name of the new molecule in acetate form name is 2-amino...
|
|
|
US20080063689 |
Dietary supplements containing anthocyanins and methods for using same to enhance creatine absorption and vasodilation
A problem with optimizing the effects of creatine has been the need to utilize large amounts of high glycemic carbohydrates to spike insulin in order to augment the flow of creatine (and other...
|
|
|
US20080058363 |
PHARMACEUTICAL COMPOSITION FOR TREATING FECAL INCONTINENCE AND ANAL ITCH
Fecal incontinence and anal itch can be treated by administration, more particularly by local application to the anus, of an α adrenergic blocker, nitric oxide synthase inhibitor, prostaglandin F...
|
|
|
US20080051330 |
Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
Novel compositions and methods of treating and preventing a viral infection are provided. A method of blocking a viral infection facilitated by a serine proteolytic (SP) activity is disclosed,...
|
|
|
US20080008694 |
METHODS TO PREVENT AND TREAT DISEASES
This invention discloses methods and compositions that can treat a variety of tissue injuries and infections. Tissue-derived leukocyte chemotactic factors are rapidly released after injury to...
|
|
|
US20080003208 |
Creatine-ligand compounds and methods of use thereof
The present invention provides methods of treating creatine responsive states, such as a neurological disorder (i.e., Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and...
|